{"id":16972,"date":"2023-01-26T00:00:00","date_gmt":"2023-01-26T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/"},"modified":"2023-05-01T14:36:14","modified_gmt":"2023-05-01T14:36:14","slug":"practical-theorist-13-fentanyl-why-fentanyl-why-now","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/pt\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","title":{"rendered":"Te\u00f3rico Pr\u00e1tico 13: Fentanil: Por que Fentanil\/Por que Agora"},"content":{"rendered":"<p class=\"rtecenter\" style=\"box-sizing: border-box; color: rgba(46, 52, 76, 0.8); font-size: 16px; font-variant-numeric: normal; font-variant-east-asian: normal; line-height: 1.7em; margin: 1.12em 0px; padding-right: 10px;\"><a href=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/cadca_pt_fentanyl_v6.pdf\"><strong style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-size: 22px;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Te\u00f3rico Pr\u00e1tico 13: Fentanil: Por que Fentanil\/Por que Agora<\/span><\/span><\/strong><\/a><br \/>\n\u00a0<\/p>\n<p class=\"rtecenter\">\n<iframe loading=\"lazy\" frameborder=\"0\" height=\"315\" scrolling=\"no\" src=\"https:\/\/www.youtube.com\/embed\/ZcFtq7XJWLA\" width=\"560\"><\/iframe><\/p>\n<p class=\"rtecenter\">\n<strong style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\">Dr. Albert Terrilion<\/strong><span style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\"> (CADCA), <\/span><strong style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\">Dr. Grant Baldwin<\/strong><span style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\"> (CDC), e\u00a0<\/span><strong style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\">Sra. Merilee Fowler<\/strong><span style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\"> (MATFORCE e Community Counts) forneceu uma vis\u00e3o geral do fentanil - fentanil farmac\u00eautico e fabricado ilicitamente (IMF) - e por que \u00e9 uma das subst\u00e2ncias mais perigosas que circulam em todo o pa\u00eds. Os apresentadores enfocaram seus efeitos em popula\u00e7\u00f5es vulner\u00e1veis, particularmente jovens, e discutiram maneiras de implementar diferentes estrat\u00e9gias (ou seja, as Sete Estrat\u00e9gias de CADCA para Mudan\u00e7a Comunit\u00e1ria) para melhorar ainda mais os esfor\u00e7os de preven\u00e7\u00e3o.<\/span><\/p>\n<p>\u00a0<\/p>\n<div style=\"box-sizing: border-box; color: rgba(46, 52, 76, 0.8); font-size: 16px; font-variant-numeric: normal; font-variant-east-asian: normal; text-align: center;\">\n<div style=\"text-align:center\">\n<figure class=\"image\" style=\"display:inline-block\"><a href=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/cadca_pt_fentanyl_v6-1.pdf\"><img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"518\" src=\"https:\/\/cadca.org\/sites\/default\/files\/ptfentanyl.png\" width=\"400\" \/><\/a><\/p>\n<p><figcaption><a href=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/cadca_pt_fentanyl_v6.pdf\">Baixe Agora<\/a><\/figcaption><\/p>\n<\/figure>\n<\/div>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">O fentanil \u00e9 uma das subst\u00e2ncias mais perigosas que circulam nas comunidades da Am\u00e9rica. \u00c9 um opioide sint\u00e9tico que \u00e9 at\u00e9 50 vezes mais forte que a hero\u00edna e 100 vezes mais forte que a morfina (DEA Fentanyl Factsheet, 2020). Apenas 2 mg de fentanil \u2013 o equivalente a alguns gr\u00e3os de sal \u2013 podem ser letais, principalmente para jovens, adultos jovens ou outras pessoas que nunca usaram fentanil ou outros opioides (EMCDDA, 2011).<\/span><\/span><\/p>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Aumentos significativos nas mortes por overdose envolvendo opioides sint\u00e9ticos, particularmente fentanil fabricado ilicitamente, come\u00e7aram em 2013 (Gladden, Martinez &amp; Seth, 2016; O&#039;Donnell, Gladden &amp; Seth, 2016; O&#039;Donnell, Halpin, Mattson, Goldberger &amp; Gladden; 2017). De 2013 a 2019, a taxa de mortalidade por fentanil e outros opioides sint\u00e9ticos saltou de 1,0 para 11,4 por 100.000 pessoas \u2013 um aumento de 1.040% (Mattson, CL, Tanz, LJ, Quinn, K., et. al., 2021). E desde 2020, dados provis\u00f3rios do Sistema Nacional de Estat\u00edsticas Vitais continuam a documentar uma tend\u00eancia crescente de mortes por overdose (Ahmad, 2022), impulsionadas em grande parte por opioides sint\u00e9ticos, como o fentanil. Estima-se que at\u00e9 2029, mais de 1,2 milh\u00e3o de pessoas morrer\u00e3o de fentanil e outros opioides se nenhuma a\u00e7\u00e3o for tomada (Rao, IJ., Humphreys K., Brandeau ML., 2021).<\/span><\/span><\/p>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Tend\u00eancias recentes de mortes por overdose entre jovens envolvendo fentanil, bem como hist\u00f3rias individuais de trag\u00e9dias, est\u00e3o chamando mais aten\u00e7\u00e3o para essa quest\u00e3o entre os jovens (Ahmad, 2022; Hoffman J., 2022). H\u00e1 uma s\u00e9rie de raz\u00f5es pelas quais os jovens est\u00e3o em risco, incluindo, entre outros, um mercado onde as drogas que cont\u00eam fentanil est\u00e3o mais dispon\u00edveis e acess\u00edveis \u2013 inclusive em p\u00edlulas falsificadas comumente dispon\u00edveis para jovens e adultos jovens por meio de plataformas de m\u00eddia social (DEA Press Release, 2021); falta de exposi\u00e7\u00e3o pr\u00e9via a opioides, o que torna as drogas com pequenas quantidades de fentanil mais propensas a serem letais; falta de conhecimento sobre o fentanil e sua presen\u00e7a em outras subst\u00e2ncias (Fentanylawarenessday.org, 2022); e a maior necessidade de abordar a conex\u00e3o, resili\u00eancia e outros fatores de prote\u00e7\u00e3o dos jovens, dados os impactos negativos da pandemia de COVID-19 na sa\u00fade mental dos jovens (Jones SE., 2022). Esses fatores tornam a necessidade de esfor\u00e7os de preven\u00e7\u00e3o prim\u00e1ria mais importante do que nunca.<\/span><\/span><\/p>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Dada a urg\u00eancia e a magnitude da crise dos opioides, que atualmente est\u00e1 sendo impulsionada pelo aumento na disponibilidade de fentanil altamente letal fabricado ilicitamente, \u00e9 fundamental focar na preven\u00e7\u00e3o prim\u00e1ria e ser informado sobre outros trabalhos para salvar vidas. Concentrar-se em estrat\u00e9gias de preven\u00e7\u00e3o prim\u00e1ria, como aumentar a conscientiza\u00e7\u00e3o e promover fatores de prote\u00e7\u00e3o em escolas e comunidades, pode ajudar a aprimorar estrat\u00e9gias mais amplas usadas para reverter o aumento de mortes por overdose, como parcerias colaborativas com sa\u00fade p\u00fablica\/seguran\u00e7a p\u00fablica; pr\u00e1ticas seguras de prescri\u00e7\u00e3o; acesso a programas de tratamento e recupera\u00e7\u00e3o do uso de subst\u00e2ncias; e promo\u00e7\u00e3o de servi\u00e7os como distribui\u00e7\u00e3o de naloxona, tiras de teste de fentanil e programas de servi\u00e7os de seringas.<\/span><\/span><\/p>\n<p class=\"rtecenter\" style=\"box-sizing: border-box; line-height: 1.7em; margin: 1.12em 0px; padding-right: 10px;\">\u00a0<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now \u00a0 Dr. Albert Terrillion (CADCA), Dr. Grant Baldwin (CDC), and\u00a0Ms. Merilee Fowler (MATFORCE<\/p>","protected":false},"author":23,"featured_media":16973,"template":"","resource_type":[290],"drug_specific_issues":[311,295],"action_to_do":[],"class_list":["post-16972","resource","type-resource","status-publish","has-post-thumbnail","hentry","resource_type-practical-theorist","drug_specific_issues-emerging-drug-trends","drug_specific_issues-synthetic-drugs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/pt\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA\" \/>\n<meta property=\"og:description\" content=\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now \u00a0 Dr. Albert Terrillion (CADCA), Dr. Grant Baldwin (CDC), and\u00a0Ms. Merilee Fowler (MATFORCE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/pt\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-01T14:36:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\" \/>\n\t<meta property=\"og:image:width\" content=\"621\" \/>\n\t<meta property=\"og:image:height\" content=\"808\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\",\"url\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\",\"name\":\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA\",\"isPartOf\":{\"@id\":\"https:\/\/www.cadca.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\",\"datePublished\":\"2023-01-26T00:00:00+00:00\",\"dateModified\":\"2023-05-01T14:36:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage\",\"url\":\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\",\"contentUrl\":\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\",\"width\":621,\"height\":808},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cadca.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cadca.org\/#website\",\"url\":\"https:\/\/www.cadca.org\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cadca.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/pt\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","og_locale":"pt_PT","og_type":"article","og_title":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA","og_description":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now \u00a0 Dr. Albert Terrillion (CADCA), Dr. Grant Baldwin (CDC), and\u00a0Ms. Merilee Fowler (MATFORCE","og_url":"https:\/\/www.cadca.org\/pt\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","og_site_name":"CADCA","article_modified_time":"2023-05-01T14:36:14+00:00","og_image":[{"width":621,"height":808,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","url":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","name":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage"},"image":{"@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","datePublished":"2023-01-26T00:00:00+00:00","dateModified":"2023-05-01T14:36:14+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage","url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","contentUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","width":621,"height":808},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource\/16972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource\/16972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/media\/16973"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/media?parent=16972"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource_type?post=16972"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/drug_specific_issues?post=16972"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/action_to_do?post=16972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}